Mission and purpose is charitable and scientific within the meaning of Section 501c3 IRC, including making distributions to exempt organizations. Specifically, purpose is to raise funds and awareness to support research into blood related diseases.
FORM 1023-EZ for ROGER ABBOTT FOUNDATION FOR BLOOD DISEASE RESEARCH INC
N/AROGER ABBOTT FOUNDATION FOR BLOOD DISEASE RESEARCH INC is a based in PEWAUKEE, WI, focused on Medical Research causes , specifically Fund Raising and/or Fund Distribution. Established in November 2023, it operates as an independent corporation and contributions to this organization are tax-deductible .
With total assets of $0.00, this ranks 1,201,816 among 2,656,690 nonprofits nationally (Top 46%), demonstrating moderate financial capacity relative to its peers. At the state level, it stands at 34,408 out of 53,071 organizations in WI (Top 65%).
In waukesha county, WI, the organization ranks 1,779 out of 3,619 nonprofits by assets (Top 49%), while locally in pewaukee, it stands at 161 among 221 organizations (Top 70%).
The organization reported no revenue in the most recent filing period, placing it at 1,071,707 nationally and 20,951 in WI.
Within its specific NTEE classification (H12 - H: Medical Research), which includes 1,661 similar organizations, ROGER ABBOTT FOUNDATION FOR BLOOD DISEASE RESEARCH INC ranks 1,302 in assets (Top 78%) and 1,185 in revenue (Top 71%).
Note: This organization's tax-exempt status was temporarily revoked on May 15, 2023 and was reinstated on May 15, 2023 .
The organization files a 990 - Required to file Form 990-N - Income less than $25,000 per year and operates on a November fiscal year. Additional information can be found at N/A.
Disclaimer: While we are confident of the accuracy of the information on this page, we encourage you verify the information directly with IRS. The IRS has a toll-free number for this at 1-877-829-5500 or visit www.irs.gov.
Login to:
Register to:
Use the link provided to create your password, log in, and gain access to the 501c3 Lookup platform.